EUGenMed Final conference
“Presentation of the Roadmap”
Tuesday, 30th June 2015, 8.15-16.30 at: The Permanent Representation of the
Federal Republic of Germany to the European Union, Rue Jacques de Lalaing 8-14,
1040 Brussels, Belgium.
Through the establishment of a European Gender Health Network and several thematic workshops,the European Gender Medicine Project (EUGenMed) developeda roadmap for the implementation of sex and gender in biomedicine and health research.
We produced diverse instruments (position papers, policy briefs, review papers, implementation, recommendations, slides etc.) to aid the incorporation of sex and gender within the areas of medical research, health care and policy. Now, at our final conference, we will present these products and collectively define the road for future implementation.
Programme:
8.15-9.45 Registration and coffee, informal discussions with project leaders
9.45-10.00 Welcome by the official host The Permanent Representation of the
Federal Republic of Germany to the European Union.
10.00-10.15 Welcome and representation of EUGenMed Project Partners
- Charité: Vera Regitz-Zagrosek,
- UM: Ineke Klinge,
- EIWH: Peggy Maguire,
10.15-10.30 Overview on the EUGenMed Project goals – The roadmap Vera Regitz-Zagrosek
10.30-11.45 Results from WS clinical medicine and pharmacology (1.1) and basic
research (1.3)
Chairs: Vera Regitz-Zagrosek/Angela Maas
- Sex and gender issues in clinical cardiology Angela Maas, The Netherlands
- Drug therapy Karin Schenck-Gustafsson, Sweden
- Basic research Vera Regitz-Zagrosek, Germany
- Discussion with all stakeholders
11.45-12.45 Results from WS on public health and prevention (1.2)
Chairs: Ineke Klinge
- Facts in public health Lucie Dalibert, The Netherlands
- Implementation into public health practice and policy Sabine Oertelt-Prigione, Germany
- Discussion with stakeholders
12.45-13.45 Lunch
13.45-14.30 Results from WS 1.4 –part a: medical education
Chair and introduction: Peggy Maguire
- Medical education EIWH/ Petra Verdonk, The Netherlands
- eGender learning at Charité Ute Seeland, Germany
- Discussion with stakeholders
14.30-15.15 Results from WS 1.4 – part b: Medicines regulation
Chairs and brief introduction: Hildrun Sundseth
- Medicines regulation and gender aspects,the view of EMA: Thorsten Vetter, UK
- Discussion with stakeholders
15.15-15.30 Coffee break
15.30-16.30 Round table: “Sustainability of a Gender sensitive roadmap for future health in Europe”
Podium: Thorsten Vetter, Marek Glezerman, Katrín Fjeldsted, Ingrid Klingmann,
Vera Regitz-Zagrosek, Ineke Klinge, Hildrun Sundseth
